Arizton published the latest research report, “Infection Control Surveillance Solutions Market – Global Outlook & Forecast 2023-2028”, Industry Trends, Growth, Opportunity Company Analysis. The global infection control surveillance solutions market will reach USD 1.23 billion by 2028, growing at a CAGR of 13.47% from 2022-2028.
To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3914
The in-depth analysis unveils the current state of the global infection control surveillance solutions market with projections till 2028. A comprehensive report has been unveiled, shedding light on the prevailing landscape of the global infection control surveillance solutions market and its anticipated dynamics spanning from 2023 to 2028. The report offers a meticulous exploration of various factors propelling market growth, impeding factors, and emerging trends. Encompassing a thorough assessment of the sector’s demand and supply facets, the study also encompasses detailed evaluations and profiles of key industry players and several notable enterprises contributing significantly to the domain.
Infection Control Surveillance Solutions Market Report Scope
|Market Size (2028)||USD 1.23 Billion|
|Market Size (2022)||USD 580.42 Million|
|Market Size (2022)||13.47%|
|Market Segments||Solution Type, Infection Type, End-user, and Geography|
|Geographic Analysis||North America, Europe, APAC, Latin America, and Middle East & Africa|
To Get the Benefit of Our Free Report Customization Service, Send Your Enquiry Here – https://www.arizton.com/customize-report/3914
North America accounted for the largest share of the global infection control surveillance solutions market and is projected to grow at 12.70% CAGR during the forecast period. This can be attributed to the region’s highly developed healthcare system and the high availability of government funds for research activities. In addition, the region is witnessing strong investments in various aspects of the healthcare industry, including diagnosis and infection control, thereby driving the growth of the infection control surveillance solutions market.
Europe is the second-largest infection control surveillance solutions market and is expected to register a CAGR of 13.82% over the forecast period. This can be attributed to the availability of a well-developed healthcare system, the government initiative to promote new technologies such as ICSS in health services, and innovative technologies such as cloud computing, predictive analytics, and ML in the region. In addition, the presence of many leading market players, such as the European Registry for Emerging Infectious Diseases (EREN) and Automated Healthcare Solutions, is driving the growth of the European infection control surveillance solutions market.
Market Segmentation Overview
Solution Type: the software solution type segment dominated the global infection control surveillance solutions market in 2022. Infection control surveillance solutions have become increasingly important tools for healthcare providers and organizations in recent years. These solutions are designed to track and prevent the spread of infection in healthcare settings and can range from simple protocols to complex software and hardware systems. On-premises infection control surveillance solutions provide healthcare providers with a comprehensive suite of infection control tools while offering the benefits of a secure, offline environment. Further, hardware-based solutions are the core of effective on-premises infection control surveillance solutions. Secure databases allow organizations to track patient data, such as infections and immunizations, in one secure and centralized location.
Infection Type: the global infection control surveillance solutions market by infection type as bloodstream infection (BSI), urinary tract infection (UTI), pneumonia (HAP & VAP), surgical site infection (SSI), and others. The bloodstream infection (BSI) segment accounted for the largest market share, accounting for over 33% in 2022. Bloodstream infections, or bacteremia, are serious and potentially life-threatening health conditions caused by bacteria entering the bloodstream. Infectious disease surveillance is a primary infection control and surveillance solution to prevent and manage bloodstream infections. This monitoring system allows for the early detection of infection and the identification of any individual experiencing septicemia. To do this, healthcare providers must collect data regarding any patient they believe may be at risk of developing a bloodstream infection. This data includes demographic information such as age and gender and any risk factor the patient may have, such as a chronic medical condition.
End-User: the hospital end-user segment accounted for the largest global infection control surveillance solutions market share in 2022. Hospitals are the major sources of HAIs, and many hospitalized patients acquire pathogenic and non-pathogenic infections during their stay. Most hospitals report CLABSI, CAUTI, SSIs, and other infections during surgical procedures and prolonged stays in ICUs. Surgical procedures include the use of invasive devices, implantation, and prosthesis. The hospital segment is dominating the global market and is witnessing steady growth in the forecasted period as hospitals & clinics are the first point of care source to get tested and treated for any disease than other healthcare settings. Infection control surveillance solutions are essential for hospitals to maintain cleanliness, compliance, and safety standards. Infection control surveillance solutions provide real-time data to give healthcare providers insight into existing and potential infection challenges and guide them in making the best decisions for their patients.
Enhancing Hospital Safety and Efficiency: The Impact of Clinical Surveillance Technology and EMRs
Hospitals use various approaches to implement clinical surveillance, including EMRs, in-house solutions, and third-party solutions. Some use multiple approaches, often using an EMR and a third-party clinical solution that coordinates with the EMR workflows. While EMRs are the most used method for clinical surveillance. According to ViziLanz report, survey respondents agree that clinical surveillance technology can positively impact hospital safety, regardless of whether they use an EMR for clinical surveillance. Among survey respondents who already use the technology, widespread agreement exists about its benefits to their organizations. These span from an increased ability to identify and manage safety events to identifying infections and outbreaks sooner. In addition, 92% of hospital executives and clinical leaders whose organizations already use the technology stated that it supports their hospital’s efforts to respond to the COVID-19 pandemic.
- 1hr of free analyst discussion
- 10% of customization
Key Company Profiles
- Epic Systems
- Wolters Kluwer
- Harris Healthcare
- Medexter Healthcare
- Spacelabs Healthcare
- Vecna Technologies
- VIZZIA Technologies
- Solution Type: Software and Services
- Infection Type: Bloodstream Infection (BSI), Urinary Tract Infection (UTI), Pneumonia (HAP & VAP), Surgical Site Infection (SSI), and Others
- End-user: Hospitals, Outpatient Facilities, and Long-term Care Facilities
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Why Arizton Research Reports?
- 100% Customer Satisfaction
- 24×7 availability – we are always there when you need us.
- 200+ Fortune 500 Companies trust Arizton’s report.
- 80% of our reports are exclusive and first in the industry.
- 100% more data and analysis.
- 1000+ reports published to date.
Check Out Some of the Top Selling Research Reports:
Infectious Disease Diagnostics Market – Global Outlook and Forecast 2020-2025
UV Disinfection Equipment Market – Global Outlook and Forecast 2020-2025
Healthcare Disinfectants and Sanitizers Market – Global Outlook & Forecast 2022-2027
Hospital Acquired Infection Control Market – Global Outlook & Forecast 2022-2027
Arizton’s Expertise in the Healthcare Industry
Arizton offers syndicate and custom market intelligence & competitive intelligence solutions across MedTech, pharmaceuticals, and life sciences & biotechnology markets within the healthcare industry. Arizton’s healthcare vertical provides unbiased research and evidence-based analysis to support business decisions and comprehensive end-to-end solutions to its customers, covering all dimensions of the healthcare value chain. We track various devices (equipment, implants, and hospital supplies) and drugs (patented, generic, & OTC) across North America, Europe, APAC, Latin America, and the Middle East & Africa regions. The healthcare reports provide historic and forecast data for 20+ key countries worldwide. We track product approvals/launches, M&A activities, and collaboration/partnership activities among pharma/biotech, medical device, and life sciences companies. Our pharmaceutical portfolio tracks 15+ therapy areas with a major focus on immunology, oncology, rare & genetic diseases, dermatology, and metabolic diseases. Our medical devices and life sciences portfolio covers in-vitro diagnostics, healthcare IT, patient monitoring, cardiovascular devices, medical imaging, personal protective equipment, clinical laboratory services, and CMO/CDMO services.
Explore more healthcare reports: https://www.arizton.com/market-reports/category/healthcare-lifesciences
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.